• SENSEX 71,909.70
    -570.59 (--0.79%)
  • BANKNIFTY 54,450.75
    -182.30 (--0.33%)
  • ICICI Bank
    1,305.50 1,187.55(%)
  • NSE
    1,735.10 1,735.10(%)
  • Moneyview
    62.00 62.00(%)
  • HDFC Bank
    721.45 1,020.35(%)
  • Reliance Industries
    1,161.00 1,161.00(%)
  • Bharti Airtel
    1,726.05 1,726.05(%)
  • Kotak Mah. Bank
    435.55 452.98(%)
  • Infosys
    1,035.00 1,727.85(%)
  • Eternal
    309.80 212.55(%)
  • Molbio Diagnosti
    1,569.80 1,686.50(%)
  • SBI
    945.55 857.30(%)
  • Hero Motors
    167.80 167.80(%)
  • PB Fintech.
    965.00 965.00(%)
  • M & M
    2,812.60 2,812.60(%)
  • T R I L
    298.70 501.25(%)
  • Cupid
    314.40 314.40(%)
  • Ather Energy
    1,372.85 566.00(%)
  • Bank of Baroda
    234.00 325.55(%)
  • A-One Steels
    469.45 469.45(%)
  • Maruti Suzuki
    11,304.30 11,304.30(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Nutraplus India Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 4534.0
  • ISIN : INE230G01020
2.10 0 (5.00%)
  • As on 01 Oct 2026 (EOD)

  • Today’s Low

    1.90

  • Today’s High

    2.10

  • Open

    1.90

  • Perv Close

    2.00

  • 52W Low

    0.00

  • 52W High

    0.00

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    7.16

  • Div & Yield %

    0.00

  • Book Value(₹)

    -1.67

  • Debt-Equity Ratio

    5.00

  • AGM Date

    13-Dec-2021

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    7.16

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    17.05

  • BV (₹)

    -1.70

  • Sales( ₹ in Cr.)

    0.00

  • NP (in Cr.)

    -0.34

  • NP Var(%)

    -579.0

  • Div%

    0.0

  • CPS (₹)

    -0.10

  • EPS (₹)

    -0.10

  • Traded Value (₹ in Lakhs)

    7.16

  • 52 Week High

    0.00

  • 52 Week Low

    0.00

  • Price BSE

    2.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    7.16

  • P/C Ratio

    -20.00

  • P/E Ratio

    -20.00

  • Price Vs.BV

    -0.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 0.00 0.00 0.00 0.00 0.10 0.02
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 0.00 0.00 0.00 0.00 0.10 0.02
Other Income 0.16 0.00 0.00 0.00 0.62 12.59
Stock Adjustments 0.00 0.00 0.00 0.00 -1.74 0.00
Total Income 0.16 0.00 0.00 0.00 -1.02 12.61
EXPENDITURE :            
Raw Materials 0.00 0.00 0.00 0.00 1.82 0.00
Power and Fuel Cost 0.00 0.00 0.00 0.00 0.00 0.00
Employee Cost 0.02 0.02 0.02 0.02 0.01 0.07
Other Manufacturing Expenses 0.00 0.00 0.00 0.00 0.00 0.00
Selling and Administration Expenses 0.48 0.03 0.04 0.10 0.02 0.11
Miscellaneous Expenses 0.00 0.00 0.00 0.01 0.04 36.16
Employee Benefit Expenses 0.02 0.02 0.02 0.02 0.01 0.07
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 -0.12 0.00
Total Expenses 0.50 0.05 0.06 0.13 2.02 36.33
Operating Profit -0.34 -0.05 -0.06 -0.13 -3.03 -23.72
Interest 0.00 0.00 0.00 0.03 0.00 0.80
Gross Profit -0.34 -0.05 -0.06 -0.16 -3.03 -24.52
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00
Profit Before Tax -0.34 -0.05 -0.06 -0.16 -3.03 -24.52
Current Tax 0.00 0.00 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00
Reported Net Profit -0.34 -0.05 -0.06 -0.16 -3.03 -24.52
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 -23.45
Adjusted Net Profit -0.34 -0.05 -0.06 -0.16 -3.03 -1.07
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward -62.57 -62.52 -62.45 -62.31 -59.28 -34.76
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -62.91 -62.57 -62.52 -62.47 -62.31 -59.28
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -0.10 -0.01 -0.02 -0.05 -0.89 -7.19
Earnings Per Share(Adj)-Unit Curr - - - - - -7.19
Book Value -1.67 -1.57 -1.55 -1.54 -1.49 -0.60
Book Value(Adj)-Unit Curr - - - - - -0.60

Shareholding Pattern

  • Promoter Group

    40.07%

  • Public Share Holding

    59.93%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 13,658,920 40.07 13,658,920 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 13,658,920 40.07 13,658,920 4
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 220 0.00 0 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 8,360 0.02 0 1
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 62,170 0.18 62,170 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 70,750 0.21 62,170 3
2] Non Institution
Bodies Corporate 577,835 1.70 559,575 55
Clearing Members 21,879 0.06 21,879 8
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 589,823 1.73 326,703 137
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 995,636 2.92 995,196 166
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 8,760,240 25.70 8,760,240 58
Individuals holding nominal share capital up to Rs. 1 lakh 9,416,003 27.62 8,395,508 8,729
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 20,361,416 59.73 19,059,101 9,153
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 34,091,086 100.00 32,780,191 9,160

Company Background

Nutraplus India LtdPharmaceuticals - Indian - Bulk Drugs

  • Nutraplus India Ltd
  • BSE Code : 4534.0
  • ISIN : INE230G01020

  • Incorporation Year

    1990

  • Registered Office

    Plot No N-92
    MIDC-Tarapur Boisar, Thane,
    Maharashtra-401506

  • Telephone

  • FAX

  • Chairman

    Mukesh Naik

  • Managing Director

    Mukesh Naik

  • Company Secretary

  • Auditor

    Raman S Shah & Associates

  • Face Value

    5

  • Listing

    BSE

  • Registrar

    Sharex Dynamic (India) Pvt Ltd
    Unit No 1 Luthra Ind,
    Andheri Kurla Road ,Safed Pool Andheri(E
    Mumbai - Mumbai - 400 072

Nutraplus India Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Nutraplus India 2.10 0.16 0.00 -23.33 0.00
Abbott India 26,832.10 7,217.19 6,929.05 35.31 43.78
Astrazeneca Phar 6,030.45 2,304.07 2,275.58 88.88 27.86
Glaxosmi. Pharma 2,774.50 3,932.76 3,790.20 44.32 58.17
Novartis India 1,967.85 393.10 354.33 49.69 15.94
Cipla 1,346.85 20,102.60 18,979.95 35.40 13.88
Bliss GVS Pharma 684.20 773.53 729.81 63.59 12.51
Fermenta Biotec. 551.35 474.15 450.25 25.74 18.77
Amrutanjan Healt 513.80 520.13 502.55 27.52 24.16
Guj. Themis Bio. 382.35 168.25 165.82 102.23 18.05
Ambalal Sarabhai 37.92 19.52 3.94 70.22 6.77